Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

被引：22

作者：

Ahmed, Yousuf ^{[1
]}

Tian, Meijuan ^{[1
]}

Gao, Yong ^{[1
]}

机构：

[1] Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, London, ON, Canada

来源：

AIDS RESEARCH AND THERAPY | 2017年 / 14卷

关键词：

HIV-1; Diversity; Broadly neutralizing antibody; Polyvalent vaccine; B cell maturation; HUMAN-IMMUNODEFICIENCY-VIRUS; POTENT NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; RHESUS-MONKEYS; SUBTYPE-B; INFECTION; RESPONSES; PROTECTION; SELECTION; IDENTIFICATION;

D O I：

10.1186/s12981-017-0178-3

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The extreme HIV diversity posts a great challenge on development of an effective anti-HIV vaccine. To solve this problem, it is crucial to discover an appropriate immunogens and strategies that are able to prevent the transmission of the diverse viruses that are circulating in the world. Even though there have been a number of broadly neutralizing anti-HIV antibodies (bNAbs) been discovered in recent years, induction of such antibodies to date has only been observed in HIV-1 infection. Here, in this mini review, we review the progress in development of HIV vaccine in eliciting broad immune response, especially production of bNAbs, discuss possible strategies, such as polyvalent sequential vaccination, that facilitates B cell maturation leading to bNAb response.

引用

页数：6

共 50 条

[31] Broadly Neutralizing Antibodies for HIV Prevention
Karuna, Shelly T.
Corey, Lawrence
[J]. ANNUAL REVIEW OF MEDICINE, VOL 71, 2020, 2020, 71 : 329 - 346
[32] Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Caskey, Marina
Klein, Florian
Nussenzweig, Michel C.
[J]. NATURE MEDICINE, 2019, 25 (04) : 547 - 553
[33] Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Marina Caskey
Florian Klein
Michel C. Nussenzweig
[J]. Nature Medicine, 2019, 25 : 547 - 553
[34] Anti-HIV neutralizing Antibodies: immunoprophylaxis and therapeutic usage in man?
Barin, Francis
[J]. VIROLOGIE, 2016, 20 (04) : 193 - 195
[35] Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Qian Wang
Linqi Zhang
[J]. Frontiers of Medicine, 2020, 14 : 30 - 42
[36] Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design
Sadanand, Saheli
Suscovich, Todd J.
Alter, Galit
[J]. ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 185 - 200
[37] VACCINE ELICITATION OF HIV BROADLY NEUTRALIZING ANTIBODIES FROM ENGINEERED B CELLS
Voss, J.
Huang, D.
Tran, J.
Abadajos, J.
Olson, A.
Saye, K.
Blane, T.
Fuller, R.
Couvrette, L.
Tenuta, M.
Li, W.
Schiffner, T.
Landais, E.
Gonzalez-Martin, A.
Sok, D.
Burton, D.
Schief, W.
Nemazee, D.
[J]. HUMAN GENE THERAPY, 2019, 30 (12) : A10 - A10
[38] Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
Peter D. Kwong
John R. Mascola
Gary J. Nabel
[J]. Nature Reviews Immunology, 2013, 13 : 693 - 701
[39] HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
Verkoczy, Laurent
Kelsoe, Garnett
Haynes, Barton F.
[J]. PLOS PATHOGENS, 2014, 10 (05)
[40] Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Wang, Qian
Zhang, Linqi
[J]. FRONTIERS OF MEDICINE, 2020, 14 (01) : 30 - 42

← 1 2 3 4 5 →